| 15.13 Data as of May 21 |  +0.03 / +0.20%Today’s Change | 13.87 Today|||52-Week Range 29.37 | -18.39% Year-to-Date |
| Previous close | 15.10 |
| Today’s open | 15.15 |
| Day’s range | -- - -- |
| Volume | 695,499 |
| Average volume (3 months) | 787,970 |
| Market cap | $746.0M |
| Dividend yield | -- |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -105.92% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | +49.55% |
| P/E ratio | 9.4 |
| Price/Sales | 2.29 |
| Price/Book | 3.73 |
| Today’s change | Today’s % change | |
|---|---|---|
| ACHNAchillion Pharmaceut... | +0.20 | +2.65% |
| CBPOChina Biologic Produ... | +0.17 | +0.65% |
| OPTROptimer Pharmaceutic... | -0.27 | -1.84% |
| NBIXNeurocrine Bioscienc... | +0.05 | +0.42% |
| Next reporting date | July 30, 2013 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $395.3M |
| Annual profit (last year) | $85.9M |
| Net profit margin | 21.74% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Adrian Adams |
Chief Financial Officer & Head-Investor Relations James E. Fickenscher, CPA |
Corporate headquarters Chesterbrook, Pennsylvania |
.
